The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I imagine we are likely done for news this week then. Shame the 'go live by end of october' message that people were pinning some hopes on turned out to be inaccurate.
I don't think he has anything in the bag yet else he would be announcing it. I agree with others that he is just stretching out the results date as much as he reasonably can do to increase the chance that something meaningful happens by then.
It's good to have a firm date to go on for news but as it's 3 weeks away, I can see the share price drifting downwards for the next week or two.
The wait continues.
The number of FDA applications was quite a nice bit of info. Gives us a bit more confidence that this isn’t an issue with GDR/DB in terms of the time it’s taking, it’s just the sheer number of applications they are having to deal with.
I will try and calm down and get over the embarrassment. It will take time but I will get through it so thank you for your concern.
I know it must be annoying for you that you have someone that calls out your lies/ramps but I will continue to do it. The fact that this morning you were ramping this event as one that Cytiva was using to 'promote their flagship PCR test' was absolutely laughable and anybody who read the synopsis would know it. Now the event happened and as expected, what you said turned out to be complete tosh.
You lied, you got called out, you reacted. If you want me to stop, then focus on positives that you can actually back up with reason.
ST, apologies for prematurely calling you a liar earlier. Once you have watched the event can you make sure you let us know where we can the part where ‘We are being promoted as the flagship mass PCR test by Cytiva to the relevant industry buyers.‘?
Thanks in advance.
Yes, Grim, so most of that is related to covid sales ultimately, so we are on the same page.
It's painfully obvious that the high share prices of companies like GDR is based upon the potential success of their covid products. Look at all the other covid based shares, the pattern is clear to see.
BB that is completely untrue and I would hope you know that.
The Turner Pope presentation was on 12th June (among other interview appearances) and the share price declined after that and only recently exceeded it on the run up to 150p in September.
Why do it?